Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing α1-antitrypsin after systemic delivery

Human Gene Therapy

Volumn 9, Issue 11, 1998, Pages 1587-1598

  O'Neal, Wanda K ^a   Zhou, Heshan ^a   Morral, Núria ^a   Aguilar Cordova, Estuardo ^b   Pestaner, Joseph ^c   Langston, Claire ^c   Mull, Benjamin ^a   Wang, Yufen ^a   Beaudet, Arthur L ^a   Lee, Brendan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; VIRUS PROTEIN;

ADENOVIRUS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; HEPATITIS; HISTOLOGY; LIVER CELL; LIVER FUNCTION TEST; LIVER HYPERTROPHY; LIVER TOXICITY; MOUSE; NONHUMAN; THROMBOCYTOPENIA; VIRUS IMMUNITY; VIRUS MUTANT;

ADENOVIRIDAE; ANIMALIA;

EID: 17344374017     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.11-1587     Document Type: Article

References (10)

1. AMALFITANO, A., BEGY, C.R., and CHAMBERLAIN, J.S. (1996). Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. U.S.A. 93, 3352-3356.
2. ARMENTANO, D., SOOKDEO, C.C., HEHIR, K.M., GREGORY, R.J., ST. GEORGE, J.A., PRINCE, G.A., WADSWORTH, S.C., and SMITH, A.E. (1995). Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6, 1343-1353.
3. ARMENTANO, D., ZABNER, J., SACKS, C., SOOKDEO, C.C., SMITH, M.P., ST. GEORGE, J.A., WADSWORTH, S.C., SMITH, A.E., and GREGORY, R.J. (1997). Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71, 2408-2416.
4. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.-W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. U.S.A. 92, 1401-1405.
5. DOBNER, T., HORIKOSHI, N., RUBENWOLF, S., and SHENK, T. (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470-1473.
6. DUCHROW, M., SCHLUTER, C., KEY, G., KUBBUTAT, M.H.G., WOHLENBERG, C., FLAD, H.-D., and GERDES, J. (1995). Cell proliferation-associated nuclear anigen defined by antibody Ki-67: A new kind of cell cycle-maintaining proteins. Arch. Immunol. Ther. Exp. (Warsz.) 43, 117-121.
7. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994b). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. U.S.A. 91, 6196-6200.
8. FANG, B., EISENSMITH, R.C., LI, X.H.C., FINEGOLD, M.J., SHEDLOVSKY, A., DOVE, W., and WOO, S.L.C. (1994). Gene therapy for phenylketonuria: Phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1, 247-254.
9. - recombinant adenoviral vectors containing a temperature-sensitive E2a mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 3, 217-222.
10. ZHOU, H., O'NEAL, W.K., MORRAL, N., and BEAUDET, A.L. (1996). Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. J. Virol. 70, 7030-7038.